Sensing Gene-Regulatory Hyperglycemic Changes by Set7 in Vascular Endothelial Cells (p 1067)
Histone modifier, Set7, activates proinflammatory genes in response to high blood glucose, report Okabe et al.
Histone proteins in chromatin can be posttranslationally modified in a number of different ways, and these modifications can be indicative of particular states of gene expression. For example, the addition of a methyl group to lysine 4 of histone H3 is associated with gene activation. Okabe et al were studying the activation of proinflammatory genes in response to hyperglycemia and wondered if such H3 methylation might be involved. They examined Set7, an H3methylating enzyme, and found that when human epithelial cells were exposed to high glucose, the enzyme relocated to the nucleus. There, Set7 activated two proinflammatory genes, IL-8 and HMOX1. However, only IL-8 displayed H3 methylation, suggesting Set7 can activate genes independent of its methylation activity. In mice subjected to transient hyperglycemia, the same gene activation and histone methylation were observed. And, interestingly, the histone modification lasted at least 1 week. This persistence, say the authors, might explain "hyperglycemic memory," the observation that even transient spikes in blood glucose levels can activate pathophysiological pathways leading to diabetes and atherosclerosis.
Revascularization of Ischemic Skeletal Muscle by Estrogen-Related Receptor-␥ (p 1087)

Transcription factor ERR␥ prompts new blood vessel growth in ischemic muscle, report Matsakas et al.
Skeletal muscle ischemia is a common disorder that often accompanies obesity, diabetes, atherosclerosis, and other cardiovascular and metabolic diseases. In severe cases, it can lead to tissue death and limb amputation. Besides adopting a healthier lifestyle, undergoing vascular surgery is among the few available treatment options. Thus, noninvasive treatments are desperately needed. Matsakas et al now suggest that boosting muscle ERR␥ levels might be one such noninvasive approach. ERR␥ is known to activate a network of proangiogenic and oxidative metabolism factors in mouse skeletal muscle, but whether it could actually promote vascular recovery was unknown. To find out, the team occluded blood vessels in the hind limbs of mice to induce muscle ischemia. Within 1 or 2 weeks, mice that overexpressed ERR␥ showed improved revascularization, blood perfusion, and reversal of myofiber damage compared with their wild-type counterparts. The transgenic mice also displayed higher expression levels of proangiogenic factors in the ischemic muscle. The authors suggest that boosting ERR␥ levels might be a potential therapy not only for ischemia of the muscle but also for that of the heart or brain.
